[1] | D öhner H Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med, 2015,373(12):1136-1152. | [2] | Krivtsov AV, Armstrong SA . MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer, 2007,7(11):823-833. | [3] | Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML . Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev, 2007,21(21):2762-2774. | [4] | Wang QF, Li YJ, Dong JF, Li B, Kaberlein JJ, Zhang L, Arimura FE, Luo RT, Ni J, He F, Wu J, Mattison R, Zhou J, Wang CZ, Prabhakar S, Nobrega MA, Thirman MJ . Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia, 2014,28(1):138-146. | [5] | Zhou J, Wu J, Li B, Liu D, Yu J, Yan X, Zheng S, Wang J, Zhang L, Zhang L, He F, Li Q, Chen A, Zhang Y, Zhao X, Guan Y, Zhao X, Yan J, Ni J, Nobrega MA, Löwenberg B, Delwel R, Valk PJ, Kumar A, Xie L, Tenen DG, Huang G, Wang QF . PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway. Leukemia, 2014, 28(7): 1436-14-48. | [6] | Li J, He F, Zhang P, Chen S, Shi H, Sun Y, Guo Y, Yang H, Man N, Greenblatt S, Li Z, Guo Z, Zhou Y, Wang L, Morey L, Williams S, Chen X, Wang QT, Nimer SD, Yu P, Wang QF, Xu M, Yang FC . Loss of Asxl2 leads to myeloid malignancies in mice. Nat Commun, 2017,8:15456. | [7] | Yang XJ, Lu B, Sun XQ, Han CJ, Fu CL, Xu KL, Wang M, Li DJ, Chen ZC, Opal P, Wen Q, Crispino JD, Wang QF, Huang Z . ANP32A regulates histone H3 acety-lation and promotes leukemogenesis. Leukemia, 2018,32:1587-1597. | [8] | Zhu X, He F, Zeng H, Ling S, Chen A, Wang Y, Yan X, Wei W, Pang Y, Cheng H, Hua C, Zhang Y, Yang X, Lu X, Cao L, Hao L, Dong L, Zou W, Wu J, Li X, Zheng S, Yan J, Zhou J, Zhang L, Mi S, Wang X, Zhang L, Zou Y, Chen Y, Geng Z, Wang J, Zhou J, Liu X, Wang J, Yuan W, Huang G, Cheng T, Wang QF . Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet, 2014,46(3):287-293. | [9] | Bu J, Chen A, Yan X, He F, Dong Y, Zhou Y, He J, Zhan D, Lin P, Hayashi Y, Sun Y, Zhang Y, Xiao Z, Grimes HL, Wang QF, Huang G . SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. Leukemia, 2018,32(4):890-899. | [10] | Suzuki R . Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol, 2010,92(5):697-701. | [11] | Huang L, Liu D, Wang N, Ling S, Tang Y, Wu J, Hao L, Luo H, Hu X, Sheng L, Zhu L, Wang D, Luo Y, Shang Z, Xiao M, Mao X, Zhou K, Cao L, Dong L, Zheng X, Sui P, He J, Mo S, Yan J, Ao Q, Qiu L, Zhou H, Liu Q, Zhang H, Li J, Jin J, Fu L, Zhao W, Chen J, Du X, Qing G, Liu H, Liu X, Huang G, Ma D, Zhou J, Wang QF . Integrated genomic analysis identifies deregulated JAK/STAT-MYC- biosynthesis axis in aggressive NK-cell leukemia. Cell Res, 2018,28(2):172-186. | [12] | Inaba H. Greaves M, Mullighan CG . Acute lymphoblastic leukaemia. Lancet, 2013,381(9881):1943-1955. | [13] | Xu XJ, Tang YM, Song H, Yang SL, Shi SW, Wei J . Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children's hospital in China. Leuk Lymphoma, 2010,51(12):2262-2269. | [14] | Zhang Y, Gao Y, Zhang H, Zhang J, He F, Hnízda A, Qian M, Liu X, Gocho Y, Pui CH, Cheng T, Wang Q, Yang JJ, Zhu X, Liu X . PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia. Blood, 2018,131(20):2256-2261. | [15] | Li Y, Jin C, Bai H, Gao Y, Sun S, Chen L, Qin L, Liu PP, Cheng L, Wang QF . Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation. Blood, 2018,131(2):191-201. |
|